Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
Completed · Not applicable
Conditions studied: Ductal Carcinoma in Situ
In brief
The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
Key facts
- Study ID
- NCT03775213
- Run by
- Duke University
- People needed
- 322
- Starts
- 2021-10-12
- Expected to finish
- 2022-01-31
- Last updated by the study team
- 2023-01-30
Who can join
Age: 50 and older, up to 79. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Sex: Female
- Age: 50-79 years
- Has had a negative mammographic screen in the past 12 months
You may not qualify if…
- Personal history of breast cancer
Where it is running
- Duke Mammography Clinic — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.